Riiklik vähistrateegia aastateks 2007-2015 - Tervise Arengu Instituut

Richards MA, Stockton D, Babb P, Coleman MP. How many deaths have beenavoided through improvements in cancer survival? British medical Journal2000;320:895–898.Roberts PJ, Mecklin J-P. Surgeons and cancer. Ann Chir et Gyn, 89(3): 171, 2000Sant M, Aareleid T, Berrino F, Bielska-Lasota M, Carli PM, Faivre J et al. and theEUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed1990–94 – results and commentary. Ann Oncol 2003;14 (Suppl 5):v61–v118.Taub DA. Miller DC. Cowan JA. Dimick JB. Montie JE. Wei JT. Impact of surgicalvolume on mortality and length of stay after nephrectomy. Urology. 63(5); 2004:862-7Thomson H, Rahu M, Aareleid T, Gornoi K: Cancer in Estonia 1968-1992 –Incidence, Mortality, Prevalence, Survival. Tallinn: Institute of Experimental andClinical Medicine; 1996.Townsend J. Policies to halve smoking deaths. Addiction 1993;88:43-52Wenner J. Zilling T. Bladstrom A. Alvegard TA. The influence of surgical volume onhospital mortality and 5-year survival for carcinoma of the oesophagus and gastriccardia. Anticancer Research. 25(1B); 2005:419-24WHO/Food and Agriculture Organisation of the United Nations. Expert consultation.Diet, nutrition andf the prevention of chronic diseases, 2003World Health Organization Cancer Mortality Databank http://www-dep.iarc.fr; 2005World Health Organization. National Cancer Control Programmes. Policies andManagerial Guidelines, 2nd Edition. Geneva: World Health Organization; 2002.37